- Home
- NAMS vs FIZZ Comparison
NAMS vs FIZZ Comparison
Compare NAMS & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- FIZZ
- Stock Information
- Founded
- NAMS 2019
- FIZZ 1985
- Country
- NAMS Netherlands
- FIZZ United States
- Employees
- NAMS N/A
- FIZZ N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- FIZZ Beverages (Production/Distribution)
- Sector
- NAMS Health Care
- FIZZ Consumer Staples
- Exchange
- NAMS Nasdaq
- FIZZ Nasdaq
- Market Cap
- NAMS 3.1B
- FIZZ 3.4B
- IPO Year
- NAMS N/A
- FIZZ 1991
- Fundamental
- Price
- NAMS $38.74
- FIZZ $33.87
- Analyst Decision
- NAMS Strong Buy
- FIZZ Strong Sell
- Analyst Count
- NAMS 10
- FIZZ 1
- Target Price
- NAMS $43.70
- FIZZ $39.00
- AVG Volume (30 Days)
- NAMS 1.3M
- FIZZ 238.6K
- Earning Date
- NAMS 11-06-2025
- FIZZ 12-04-2025
- Dividend Yield
- NAMS N/A
- FIZZ N/A
- EPS Growth
- NAMS N/A
- FIZZ 0.66
- EPS
- NAMS N/A
- FIZZ 1.98
- Revenue
- NAMS $64,006,000.00
- FIZZ $1,202,396,000.00
- Revenue This Year
- NAMS N/A
- FIZZ $2.80
- Revenue Next Year
- NAMS N/A
- FIZZ $2.19
- P/E Ratio
- NAMS N/A
- FIZZ $16.98
- Revenue Growth
- NAMS 762.15
- FIZZ 0.46
- 52 Week Low
- NAMS $14.06
- FIZZ $32.21
- 52 Week High
- NAMS $41.47
- FIZZ $50.51
- Technical
- Relative Strength Index (RSI)
- NAMS 66.43
- FIZZ 31.99
- Support Level
- NAMS $35.50
- FIZZ $32.21
- Resistance Level
- NAMS $39.03
- FIZZ $36.71
- Average True Range (ATR)
- NAMS 2.30
- FIZZ 0.86
- MACD
- NAMS -0.16
- FIZZ -0.13
- Stochastic Oscillator
- NAMS 61.67
- FIZZ 35.02
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About FIZZ National Beverage Corp.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).